Drug name - Zejula

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8436185 GLAXOSMITHKLINE Pharmaceutically acceptable salts of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
Apr, 2029

(6 years from now)

US8071623 GLAXOSMITHKLINE Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
Mar, 2031

(8 years from now)

CN101932572A GLAXOSMITHKLINE Pharmaceutically Acceptable Salts Of 2-{4-[(3S)-Piperidin-3-Yl]Phenyl}-2H-Indazole-7-Carboxamide
Nov, 2016

(5 years ago)

CN101415686A GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Apr, 2027

(4 years from now)

CN101415686B GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly (Adp-Ribose) Polymerase (Parp) Inhibitor
Apr, 2027

(4 years from now)

CN101578279B GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

CN101578279A GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose) Polymerase(Parp) Inhibitors
Jan, 2028

(5 years from now)

IN288260B GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly (Adpribose) Polymerase (Parp) Inhibitors
Apr, 2027

(4 years from now)

IN200808150P1 GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly (Adp-Ribose)Polymerase (Parp) Inhibitors
Apr, 2027

(4 years from now)

EP2007733B1 GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Apr, 2027

(4 years from now)

EP2007733A1 GLAXOSMITHKLINE Amide Substituted Indazole And Benzotriazole Derivatives As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Apr, 2027

(4 years from now)

EP2336120B1 GLAXOSMITHKLINE Combinations Containing Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2805945A1 GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2336120A1 GLAXOSMITHKLINE Combinations Containing Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2805945B1 GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2109608A1 GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2109608B1 GLAXOSMITHKLINE Amide Substituted Indazoles As Poly(Adp-Ribose)Polymerase (Parp) Inhibitors
Jan, 2028

(5 years from now)

EP2240466B1 GLAXOSMITHKLINE Pharmaceutically Acceptable Salts Of 2-{4-[(3S)-Piperidin-3- Yl]Phenyl} -2H-Indazole-7-Carboxamide
Jan, 2029

(6 years from now)

EP2240466A1 GLAXOSMITHKLINE Pharmaceutically Acceptable Salts Of 2-{4-[(3S)-Piperidin-3- Yl]Phenyl} -2H-Indazole-7-Carboxamide
Jan, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8071579 GLAXOSMITHKLINE DNA damage repair inhibitors for the treatment of cancer Aug, 2027

(4 years from now)

US8143241 GLAXOSMITHKLINE DNA damage repair inhibitors for treatment of cancer Aug, 2027

(4 years from now)

US8859562 GLAXOSMITHKLINE Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer Aug, 2031

(8 years from now)

US11091459 GLAXOSMITHKLINE Niraparib compositions Mar, 2038

(15 years from now)

Drugs and Companies using NIRAPARIB TOSYLATE ingredient

Treatment: A method of treatment of advanced ovarian, fallopian tube, or primary peritoneal cancer associated with homologous recombination deficiency (hrd) positive status

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 100MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.